WallStreetZenWallStreetZen

NASDAQ: HURA
Tuhura Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tuhura Biosciences earnings were -$33.7M for the trailing 12 months ending Sep 30, 2025, with -99.8% growth year over year. The latest HURA earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$7.1M, down 25.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HURA reported annual earnings of -$22.6M, with -22.7% growth. The next HURA earnings date is Mar 26, 2026.

HURA past earnings growth

How has HURA's earnings growth performed historically?

Company
-99.75%
Industry
65.17%
Market
56.25%
HURA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HURA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

HURA earnings history

Current Revenue
$0.0
Current Earnings
-$33.7M
Current Profit Margin
0%

HURA Return on Equity

Current Company
-221.9%
Current Industry
-21.2%
Current Market
35.1%
HURA's Return on Equity (-221.9%)... subscribe to Premium to read more.
High Return on Equity Performance

HURA Return on Assets

Current Company
-141.9%
Current Industry
-8.8%
HURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HURA announces earnings.

HURA Return on Capital Employed

Current Company
-178.58%
Current Industry
-3.5%
HURA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HURA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HURA-$30.03M-$33.66M-99.75%$0.49
PLUR-$21.09M-$22.55MN/A-$3.12
BTAI-$51.29M-$68.21MN/A-$9.04
RVPH-$22.71M-$22.76MN/A-$0.46
KYNB$216.43M$215.65MN/A$53.48
View Top Biotech Stocks

HURA earnings dates

Next earnings date
Mar 26, 2026

Tuhura Biosciences Earnings Reports & History FAQ

What were Tuhura Biosciences's earnings last quarter?

On HURA's earnings call on Invalid Date, Tuhura Biosciences (NASDAQ: HURA) reported Q3 2025 earnings per share (EPS) of -$0.14, up 74.07% year over year. Total HURA earnings for the quarter were -$7.10 million. In the same quarter last year, Tuhura Biosciences's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Tuhura Biosciences stock.

When does Tuhura Biosciences report earnings?

The next HURA earnings date is Invalid Date. Add HURA to your watchlist to be reminded of Tuhura Biosciences's next earnings date.

Is Tuhura Biosciences profitable or losing money?

As of the last Tuhura Biosciences earnings report, Tuhura Biosciences is currently losing money. Tuhura Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$32.70 million, a 7.72% decrease year over year.

What was HURA's earnings growth in the past year?

As of Tuhura Biosciences's earnings date in Invalid Date, Tuhura Biosciences's earnings has grown -99.75% year over year. This is 164.92 percentage points lower than the US Biotechnology industry earnings growth rate of 65.17%. HURA earnings in the past year totalled -$33.66 million.

What are Tuhura Biosciences's earnings expectations?

The current EPS estimate for Tuhura Biosciences's earnings report in Invalid Date is -$0.12.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.